TP53 and neoplasm: p53, as a well-known tumor suppressor, could form biomolecular condensates when it is mutated, post-translationally modified, or interacted with its binding partners; the formation of p53 biocondensates could regulate its transcriptional activity, which might change its anticancer properties (42–45).